NEWS: 公告在东京证券交易所JASDAQ标准市场新上市

表纸
市场调查报告书

人体生长荷尔蒙 (HGH)的全球市场:产业分析与未来展望

Global Human Growth Hormone (hGH) Market: Industry Analysis & Outlook (2019-2023)

出版商 Koncept Analytics 商品编码 336016
出版日期 内容资讯 英文 99 Pages
订单完成后即时交付
价格
人体生长荷尔蒙 (HGH)的全球市场:产业分析与未来展望 Global Human Growth Hormone (hGH) Market: Industry Analysis & Outlook (2019-2023)
出版日期: 2019年03月20日内容资讯: 英文 99 Pages
简介

本报告提供全球人体生长荷尔蒙 (HGH) 市场相关调查分析,疾病、产品概要和市场动态,整体市场规模的变化及预测,各市场区隔、各国详细趋势,竞争情形,主要企业简介的资讯汇整,为您概述为以下内容。

第1章 概要

  • 人体生长荷尔蒙 (hGH)
  • hGH的生理作用
  • 生长激素缺乏症 (GHD)
  • 基因改造型人体生长荷尔蒙 (rhGH)
  • hGH市场:各症状

第2章 全球人体生长荷尔蒙市场

  • hGH市场成果值 (以金额为准)
  • hGH市场预测价值 (以金额为准)
  • hGH市场成果值 (以数量为准)
  • hGH市场预测价值 (以数量为准)
  • 各症状的市场趋势
    • 儿童性hDH市场:成果值、预测值 (以金额为准)
    • 其他hGH市场:成果值、预测值 (以金额为准)
  • 全球hGH市场:各地区

第3章 市场规模

  • 美国
    • hGH市场成果值 (以金额为准)
    • hGH市场预测价值 (以金额为准)
    • hGH市场:各症状
    • 儿童性GHD市场预测价值 (以金额为准)
  • 欧洲
  • 日本

第4章 市场动态

  • 成长推动因素
  • 市场趋势、动静
  • 课题

第5章 竞争情形

  • 全球hGH市场
    • 各企业的市场占有率
    • 纯销售额、市值比较
  • 美国的hGH市场:各企业市场占有率

第6章 企业简介

  • Novartis AG
    • 产业概要
    • 主要的财务指标
    • 产业策略
  • Pfizer Inc.
  • Eli Lilly and Company
  • Novo Nordisk A/S
目录

Human Growth Hormone (hGH) is a peptide hormone produced by the pituitary gland that stimulates growth in children and adults. It plays an important role in the functioning of the human body by regulating body fluids, muscle and bone growth and fat metabolism of the body. The deficiency of growth hormone in the body is known as growth hormone deficiency which is administered by intramuscular or subcutaneous GH injections on a daily basis. Various therapeutics products are currently in the final phase of development and are expected to be launched in the coming years.

The market is expected to experience robust growth due to the increasing prevalence of GH and long-acting growth hormone formulations in development. Rising aging population accompanied by high growth of serious chronic diseases would keep the demand for hGH drugs high and would act as the growth catalyst for the global market.

The global long-acting growth hormone market is estimated to increase at a commendable rate in future, which is mainly due to increase in research and development activities and increasing occurrence of pituitary dysfunction. TransCon is expected to dominate the market due to ease of use and high efficacy. The market will see a shift in the use of long-acting hormone drugs from daily basis products, positively impacting the market.

Geographically, the U.S. dominated the market owing to its advance healthcare infrastructure. Majority of the players are based in the U.S., thus leading to the highest revenue from this region. The U.S. human growth hormone market is anticipated to grow at a steady rate owing to high research and development efforts.

The report "Global Human Growth Hormone (hGH) Market: Industry Analysis & Outlook (2019-2023)" analyzes the development of this market along with the market opportunities. The four major players: Novartis Ag, Pfizer Inc., Eli Lilly and Company, and Novo Nordisk A/S have been profiled along with their key financials and strategies for growth. The report contains a comprehensive analysis of the global market along with the study of the regional markets.

Table of Contents

1. Market Overview

  • 1.1 Human Growth Hormone
  • 1.2 Physiological Effects of hGH
  • 1.3 GH Deficiency (GHD)
  • 1.4 Recombinant Human Growth Hormone (rhGH)
  • 1.5 hGH Market by Indications

2. Global hGH Market

  • 2.1 Global hGH Market by Value
  • 2.2 Global hGH Market Forecast by Value
  • 2.3 Global hGH Market by Volume
  • 2.4 Global hGH Market Forecast by Volume
  • 2.5 Global hGH Market Share by Indication
  • 2.6 Global hGH Market by Indication
    • 2.6.1 Global Pediatric GHD Market Forecast by Value (2018-2023)
    • 2.6.2 Global Other GHD Market Forecast by Value (2018-2023)
  • 2.7 Global hGH Market Forecast by Therapeutics
    • 2.7.1 Global TransCon GH Revenue Forecast by Value
    • 2.7.2 Global Other LAGH Market Forecast by Value
  • 2.8 Global hGH Market Forecast by Therapeutics
  • 2.9 Global hGH Market by Therapeutics
  • 2.10 Global hGH Market by Region

3. Regional Markets

  • 3.1 The U.S.
    • 3.1.1 The U.S. hGH Market Forecast by Value
    • 3.1.2 The U.S. hGH Market by Indication
    • 3.1.3 The U.S. Pediatric GH Market Forecast by Value
    • 3.1.4 The U.S. Pediatric GH Market by Indication
    • 3.1.5 The U.S. Pediatric GHD Market Forecast by Value
    • 3.1.6 The U.S. Other Pediatric Indications Market Forecast by Value
    • 3.1.7 The U.S. Adult GHD Market Forecast by Value
    • 3.1.8 The U.S. Adult GHD Market Forecast by Value
    • 3.1.9 The U.S. Pediatric GHD Patient Population Forecast
    • 3.1.10 The U.S. Pediatric GHD Patient Population by Type
    • 3.1.11 The U.S. TransCon Revenue Forecast
  • 3.2 Europe
    • 3.2.1 Europe hGH Market Forecast by Value
    • 3.2.2 Europe hGH Market by Indication
    • 3.2.3 Europe Pediatric GHD Patient Population Forecast
    • 3.2.4 Europe Pediatric GHD Patient Population by Type
    • 3.2.5 Europe TransCon Revenue Forecast
  • 3.3 Japan
    • 3.3.1 Japan hGH Market Forecast by Value
    • 3.3.2 Japan hGH Market by Indication
    • 3.3.3 Japan Pediatric GHD Patient Population Forecast
    • 3.3.4 Japan Pediatric GHD Patient Population by Type
    • 3.3.5 Japan TransCon Revenue Forecast

4. Global Human Growth Hormone Market Opportunity

  • 4.1 VRS-317
    • 4.1.1 VRS-317 - The U.S. Growth Hormone Deficiency Market
    • 4.1.2 VRS-317 - European Union (EU) Growth Hormone Deficiency Market
    • 4.1.3 VRS-317 -Japan Growth Hormone Deficiency Market
  • 4.2 TransCon hGH
    • 4.2.1 TransCon hGH -The US, Europe and Japan/ROW Growth Hormone Deficiency Market
    • 4.2.2 Clinical Development Timeline for TransCon hGH

5. Market Dynamics

  • 5.1 Growth Drivers
    • 5.1.1 Increasing Incidence of Cancer Cases
    • 5.1.2 Rise in GDP Per Capita
    • 5.1.3 Increased Spending on Medicines
    • 5.1.4 Increasing Global Healthcare Expenditure
    • 5.1.5 Long-Acting hGH Agents in Development
    • 5.1.6 Increasing Pituitary Dysfunctional Cases
  • 5.2 Trends & Development
    • 5.2.1 Use of TransCon Technology
    • 5.2.2 Development of Auto-Injectors
    • 5.2.3 Use of hGH as an Anti-Aging Therapy
  • 5.3 Challenges
    • 5.3.1 High Cost of Treatment
    • 5.3.2 High R&D Costs
    • 5.3.3 Side Effects of rhGH
    • 5.3.4 Low Share of Biosimilar

6. Competitive Landscape

  • 6.1 Global hGH Market
    • 6.1.1 Global hGH Market Volume Share by Company
    • 6.1.2 Global Long-Acting Growth Hormone Landscape by Company
  • 6.2 The U.S. hGH Market
    • 6.2.1 The U.S. hGH Market Value Share by Company

7. Company Profiles

  • 7.1 Novartis International AG
    • 7.1.1 Business Overview
    • 7.1.2 Financial Overview
    • 7.1.3 Business Strategies
  • 7.2 Pfizer, Inc.
    • 7.2.1 Business Overview
    • 7.2.2 Financial Overview
    • 7.2.3 Business Strategies
  • 7.3 Eli Lilly and Company
    • 7.3.1 Business Overview
    • 7.3.2 Financial Overview
    • 7.3.3 Business Strategies
  • 7.4 Novo Nordisk A/S
    • 7.4.1 Business Overview
    • 7.4.2 Financial Overview
    • 7.4.3 Business Strategies

List of Figures

  • hGH Secretion Control
  • hGH's Physiological Effect
  • hGH Market Segmentation by Indication
  • Global hGH Market by Value (2014-2018)
  • Global hGH Market Forecast by Value (2019-2023)
  • Global hGH Market by Volume (2014-2018)
  • Global hGH Market Forecast by Volume (2019-2023)
  • Global hGH Market Share by Indication (2018)
  • Global Pediatric GHD Market Forecast by Value (2018-2023)
  • Global Other GHD Market Forecast by Value (2018-2023)
  • Global TransCon GH Revenue Forecast by Value (2022-2028)
  • Global Other LAGH Market Forecast by Value (2022-2028)
  • Global hGH Market Forecast by Therapeutics (2028)
  • Global hGH Market Share by Daily Agents (2018)
  • Global hGH Market by Region (2018)
  • The U.S. hGH Market Forecast by Value (2018-2023)
  • The U.S. hGH Market by Indication (2018)
  • The U.S. Pediatric GH Market Forecast by Value (2018-2023)
  • The U.S. Pediatric GH Market by Indication (2018)
  • The U.S. Pediatric GHD Market Forecast by Value (2018-2023)
  • The U.S. Other Pediatric Indications Market Forecast by Value (2018-2023)
  • The U.S. Adult GHD Market Forecast by Value (2018-2023)
  • The U.S. Adult GHD Market Forecast by Value (2018-2023)
  • The U.S. Pediatric GHD Patient Population Forecast (2018-2023)
  • The U.S. Pediatric GHD Patient Population by Type (2018)
  • The U.S. TransCon Revenue Forecast (2021-2028)
  • Europe hGH Market Forecast by Value (2018-2023)
  • Europe hGH Market by Indication (2018)
  • Europe Pediatric GHD Patient Population Forecast (2018-2023)
  • Europe Pediatric GHD Patient Population by Type (2018)
  • Europe TransCon Revenue Forecast (2023-2028)
  • Japan hGH Market Forecast by Value (2018-2023)
  • Japan hGH Market by Indication (2018)
  • Japan Pediatric GHD Patient Population Forecast (2018-2023)
  • Japan Pediatric GHD Patient Population by Type (2018)
  • Japan TransCon Revenue Forecast (2023-2028)
  • Global New Cancer Patients by Volume (2014-2018)
  • Global GDP Per Capita (2014-2018)
  • Global Spending on Medicines (2010-2022)
  • Global Healthcare Expenditure (2014-2018)
  • Global Late Stage Long-Acting Growth Hormone in Progress (2018)
  • Average Annual Cost of hGH Therapy for Children and Adults
  • Global hGH Market Volume Share by Company (2018)
  • The U.S. hGH Market Value Share by Company (2018)
  • Novartis International AG Sales by Segment (2018)
  • Novartis Net Sales and Net Income (2014-2018)

List of Tables

  • The U.S. Pediatric & Adult Growth Hormone Deficiency Market of VRS-317 (2019-2024)
  • EU Pediatric & Adult Growth Hormone Deficiency Market of VRS-317 (2019-2024)
  • Japan Pediatric & Adult Growth Hormone Deficiency Market of VRS-317 (2020-2024)
  • The U.S., Europe & Japan/ROW Growth Hormone Deficiency Market of TransCon hGH (2021-2024)
  • Clinical Development Timeline for TransCon hGH (2018)
  • Global Late Stage Long-Acting Growth Hormone in Progress (2018)
  • Average Annual Cost of hGH Therapy for Children and Adults
  • Global Long-Acting Growth Hormone Landscape by Company (2018)